ASPRE试验:阿司匹林对妊娠期平均动脉压和子宫动脉搏动指数轨迹的影响
本研究为ASPRE试验的纵向二次分析,纳入1620例早产型子痫前期高风险孕妇,随机接受阿司匹林150mg/日或安慰剂。结果显示阿司匹林不影响平均动脉压轨迹,但显著降低子宫动脉搏动指数,尤其在20周前。
要点
- 阿司匹林150mg/日不改变平均动脉压轨迹。
- 阿司匹林显著降低子宫动脉搏动指数,20周前更明显。
- 子宫动脉搏动指数轨迹变化或反映阿司匹林预防子痫前期机制。
诊断标准与关键数值
- 平均动脉压MoM值治疗与孕周交互作用P=0.340,两组轨迹无显著差异。
- 子宫动脉搏动指数MoM值治疗与孕周交互作用P=0.006,阿司匹林组下降更陡峭。
临床应用与阅片要点
- 对于早产型子痫前期高风险孕妇,阿司匹林治疗期间子宫动脉搏动指数下降更明显,尤其20周前。
- 平均动脉压轨迹不受阿司匹林影响,解读血压变化时需考虑此因素。
局限性
- 本研究为ASPRE试验的二次分析,结果需谨慎解读。
- 研究仅纳入早产型子痫前期高风险孕妇,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The mechanism by which aspirin prevents pre-eclampsia is poorly understood, and its effects on biomarkers throughout pregnancy are unknown. We aimed to investigate the effects of aspirin on mean arterial pressure (MAP) and mean uterine artery pulsatility index (UtA-PI) using repeated measures from women at increased risk of preterm pre-eclampsia.
METHODS: This was a longitudinal secondary analysis of the Combined Multimarker Screening and Randomized Patient Treatment with Aspirin for Evidence-Based Pre-eclampsia Prevention (ASPRE) trial using repeated measures of MAP and UtA-PI. In the trial, 1620 women at increased risk of preterm pre-eclampsia were identified using the Fetal Medicine Foundation algorithm at 11 + 0 to 13 + 6 weeks, of whom 798 were randomly assigned to receive 150 mg/day aspirin and 822 were assigned to receive placebo daily from 11-14 weeks to 36 weeks of gestation or delivery, whichever came first. MAP and UtA-PI were measured at baseline and follow-up visits at 19-24, 32-34 and 36 weeks of gestation. Generalized additive mixed models with treatment by gestational age interaction terms were used to investigate the effects of aspirin on MAP and UtA-PI trajectories over time.
RESULTS: Among 798 participants in the aspirin group and 822 in the placebo group, there were 5951 MAP and 5942 UtA-PI measurements. Trajectories of raw and multiples of the median (MoM) values of MAP did not differ significantly between the two groups (MAP MoM analysis: P-value for treatment by gestational age interaction, 0.340). In contrast, trajectories of raw and MoM values of UtA-PI showed a significantly steeper decline in the aspirin group than in the placebo group, with the difference mainly driven by a more pronounced reduction before 20 weeks of gestation (UtA-PI MoM analysis: P-value for treatment by gestational age interaction, 0.006).
CONCLUSIONS: In women at increased risk of preterm pre-eclampsia, 150 mg/day aspirin initiated in the first trimester does not affect MAP but is associated with a significant decrease in mean UtA-PI, particularly before 20 weeks of gestation. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Rolnik DL, Syngelaki A, O'Gorman N, et al. ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy. Ultrasound Obstet Gynecol. 2023. PMID: 37058400. doi:10.1002/uog.26222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。